Blog

Further investigation of microtubular system, namely full understanding its assembly, dynamics and regulation, is an incentive goal both for clinical and basic researchers.

Today we introduce two new antibody clones, that have been added to our portfolio:
Anti-histone deacetylase 6 (HDAC6) - clone 159
Anti-human CD51/CD61 complex (extracellular epitope) - clone 23C6

Higher expression of RPSA is characteristic for many carcinomas, and correlates with their invasivity and metastatic potential.

The mouse monoclonal antibody JOVI.1, recognizing an extracellular epitope on TCR Cbeta1 (TRBC1), is suitable for flow cytometry, immunoprecipitation, and immunohistochemistry (frozen sections). It is popular as a tool for analysis of T cell-mediated diseases.

We are proud to inform you that in March 2020 in Cytometry B (Clinical cytometry) a paper was released having one of our colleagues from EXBIO Praha team Miro Benko (Director, Product Development Department) as a co-author.

Recently developed strategy for prevention of cancer relapse due to acquired radioresistance may be based on immunotherapies. One promising approach is based on genetically modified T cells expressing chimeric antigen receptors (CAR).

New challengies in the diagnostics of allergies

Intended use: Development of qualitative and quantitative allergy tests and assays for assesment of patients reactivity profiles or follow up of allergic patients during immunotherapy.

EXBIO the leading manufacturer of monoclonal antibodies and reagents for research and clinical applications with the focus on multi-color flow cytometry analysis of human cellular markers, is pleased to announce its acquisition of Apronex 
 
PRESS RELEASE

In addition to ACE2 and TMPRSS2, also other host cell surface proteins may be involved in the interactions with the SARS-CoV-2 virus. It has been known since 2005 that broadly expressed transmembrane glycoprotein of the immunoglobulin superfamily CD147 (also known as basigin or EMMPRIN) facilitates SARS-CoV invasion for host cells.
 
Here we present a short communication of Prof. Vaclav Horejsi, PhD (IMG AS CR) on this Hot Topic.

EXBIO has recently developed two new products for multicolor flow-cytometric immunophenotyping of cells of the human immune system from peripheral blood to follow up kinetics of immune responses in relation to clinical and virological features of a COVID-19 patients.
Now, we bring you a presentation of patient’s data – comparision with percentage range acquired from normal healthy donors and time-course changes in subpopulations of B and T cells of hospitalized patients diagnosed with COVID-19.

While the COVID-19 pandemic rises exponentially influencing daily life of all of us, EXBIO decided to face the situation and focus all our effort on development of two Dry Reagent kits for cytometric analysis of T and B cell populations. Our goal was to provide all laboratories  with an efficient, reliable and fast tool for analyzing carefully selected cellular subpopulations important for characterizing the patient's samples. 

EXBIO Praha, a.s. is pleased to ensure you that we maintain production and regular delivery of our products to customers, while of course protecting our employees’ health with maximum safety measures.